DA
DCF Advisers Portfolio holdings
AUM
$208M
This Quarter Return
+9.93%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$148M
AUM Growth
+$148M
(+3%)
Cap. Flow
-$7.31M
Cap. Flow
% of AUM
-4.95%
Top 10 Holdings %
Top 10 Hldgs %
49.62%
Holding
88
New
3
Increased
17
Reduced
30
Closed
9
Top Buys
| 1 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$2.02M |
| 2 |
Alibaba
BABA
|
$1.28M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$1.16M |
| 4 |
Lifecore Biomedical
LFCR
|
$860K |
| 5 |
Yeti Holdings
YETI
|
$518K |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$2.33M |
| 2 |
AbbVie
ABBV
|
$1.86M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
$1.38M |
| 4 |
AT&T
T
|
$1.07M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
$986K |
Sector Composition
| 1 | Healthcare | 39.95% |
| 2 | Technology | 21.46% |
| 3 | Communication Services | 8.48% |
| 4 | Consumer Discretionary | 5.11% |
| 5 | Financials | 4.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Micron Technology
MU
$133B
| $13.2M | 7.18% | 155,000 -8,000 | -5% | -$683K |
|
|
2
Regeneron Pharmaceuticals
REGN
$61.5B
| $10.7M | 5.81% | 12,200 +1,325 | +12% | +$1.16M |
|
3
Alphabet (Google) Class C
GOOG
$2.58T
| $9.89M | 5.37% | 70,150 | – | – |
|
4
argenx
ARGX
$43.6B
| $7.78M | 4.22% | 20,450 -1,550 | -7% | -$590K |
|
|
ITCI
5
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.94M | 3.76% | 96,857 -10,300 | -10% | -$738K |
|
6
Advanced Micro Devices
AMD
$264B
| $5.6M | 3.04% | 38,000 -2,700 | -7% | -$398K |
|
|
7
AbbVie
ABBV
$372B
| $5.04M | 2.73% | 32,500 -12,000 | -27% | -$1.86M |
|
8
Xencor
XNCR
$580M
| $5.03M | 2.73% | 237,107 -9,193 | -4% | -$195K |
|
9
Oracle
ORCL
$635B
| $4.64M | 2.52% | 44,000 +1,500 | +4% | +$158K |
|
10
SPDR Gold Trust
GLD
$107B
| $4.4M | 2.39% | 23,000 +1,500 | +7% | +$287K |
|
11
Bank of America
BAC
$376B
| $4.34M | 2.35% | 128,750 -750 | -0.6% | -$25.3K |
|
12
Energy Transfer Partners
ET
$60.8B
| $4.28M | 2.32% | 310,000 -63,000 | -17% | -$869K |
|
13
Eli Lilly
LLY
$657B
| $4.08M | 2.21% | 7,000 -500 | -7% | -$291K |
|
14
iShares Gold Trust
IAU
$50.6B
| $3.9M | 2.12% | 100,000 | – | – |
|
15
Prothena Corp
PRTA
$441M
| $3.05M | 1.66% | 84,000 +1,050 | +1% | +$38.2K |
|
|
16
Alibaba
BABA
$322B
| $2.93M | 1.59% | 37,800 +16,500 | +77% | +$1.28M |
|
17
Apple
AAPL
$3.45T
| $2.84M | 1.54% | 14,750 | – | – |
|
18
Incyte
INCY
$16.5B
| $2.67M | 1.45% | 42,500 -2,000 | -4% | -$126K |
|
19
iShares Russell 2000 ETF
IWM
$67B
| $2.31M | 1.25% | 11,500 | – | – |
|
|
RVNC
20
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.26M | 1.23% | 256,872 +230,372 | +869% | +$2.02M |
|
21
Zimmer Biomet
ZBH
$21B
| $2.24M | 1.22% | 18,397 | – | – |
|
22
Turning Point Brands
TPB
$1.79B
| $2.2M | 1.19% | 83,500 | – | – |
|
23
Nuveen Credit Strategies Income Fund
JQC
$754M
| $2.16M | 1.17% | 414,000 -6,000 | -1% | -$31.3K |
|
|
AOD
24
abrdn Total Dynamic Dividend Fund
AOD
$963M
| $2.11M | 1.14% | 261,500 +8,000 | +3% | +$64.5K |
|
25
Amgen
AMGN
$155B
| $2.02M | 1.09% | 7,000 -1,400 | -17% | -$403K |
|